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Abstract
Background: Detecting and managing frailty at early stages can prevent disability and other adverse outcomes. The study aim was to evaluate 
whether a multifactorial intervention program could modify physical and cognitive frailty parameters in elderly individuals.
Methods: We conducted a multicenter, randomized, single-blind, parallel-group trial in community-living prefrail/frail elderly individuals in 
Barcelona. A total of 352 patients, aged ≥65 years old with positive frailty screening, was randomized into two groups to receive a 12-week 
multidisciplinary intervention or usual care, with concealed allocation. The intervention consisted of: exercise training, intake of hyperproteic 
nutritional shakes, memory training, and medication review. Main outcome assessments with multivariate analysis were conducted at 3 and 
18 months.
Results: A total of 347 participants (98.6%) completed the study, mean age 77.3 years, 89 prefrail subjects (25.3%), and 75.3% female 
(n = 265). Eighteen-month assessments were performed in 76% of the sample. After 3 and 18 months, adjusted means difference between-
groups showed significant improvements for the intervention group in all comparisons: Short Physical Performance Battery score improved 
1.58 and 1.36 points (p < .001), handgrip strength 2.84 and 2.49 kg (p < .001), functional reach 4.3 and 4.52 cm (p < .001), and number 
of prescriptions decreased 1.39 and 1.09 (p < .001), respectively. Neurocognitive battery also showed significant improvements across all 
dimensions at 3 and 18 months.
Conclusions: A physical, nutritional, neurocognitive, and pharmacological multifaceted intervention was effective in reversing frailty measures 
both at short-term and 18 months. Lasting benefits of a multi-intervention program among frail elderly individuals encourage its prioritization.
Keywords: Frailty, Clinical Trials, Exercise, Cognition
Frailty, defined as vulnerability to multiple stressors (1), is a frequent 
geriatric condition. Nevertheless, its conceptualization, based on two 
major approaches: the phenotype model (2) or an accumulation of 
deficits (3), remains a challenge. Irrespective of the model employed, 
frailty predicts main adverse outcomes such as mobility loss, falling, 
disability, hospitalization, institutionalization, and mortality (4), and 
results in considerable medical and public expenditure. Frailty is a con-
tinuum: from a prefrail stage to mild impairment without a total loss 
of function (5). Due to its potential reversibility at early stages, it is vital 
to assess the individual’s degree of frailty (6). In fact, interventions to 
achieve healthy aging through prevention programs are currently pri-
orities expressed by the World Health Organization (WHO) and recent 
European policies (7).
Although frailty is a multidimensional concept embracing physi-
cal, psychological, and environmental factors, most intervention 
studies have focused only on a one-dimensional, biomedical perspec-
tive (8). Rehabilitation models present satisfactory results in gait 
speed and improvement of the score in the short physical perfor-
mance battery (SPPB) (9), but report inconclusive effects on func-
tional ability and well-being (10).
A considerable number of protocols have been performed in insti-
tutions (11), at individuals’ homes (12), and with a small sample size of 
community-dwelling older adults (13). Other interventions have only 
encompassed strategies based on nutritional supplementation or hor-
mones. They partially failed to decelerate the sarcopenia process, and 
revealed an unfavorable safety profile (14,15). Protein intake alone 
or combined with physical activity is the main nonpharmacological 
modality that effectively stimulates muscle protein synthesis (16).
Furthermore, elderly patients frequently present cognitive disor-
ders (executive function, attention, processing speed), together with 
affected emotional and social domains, which may trigger a rapid 
decline. To date, however, the relationship between frailty and cogni-
tive states remains unclear (17). Cognitive impairment as a key element 
in frailty characterization has been widely debated (18). Physical activ-
ity appears to enhance cognitive performance in risk patients and when 
combined with protein supplementation, although results are inconclu-
sive (19). Memory stimulation programs also lead to positive perfor-
mance changes in older adults with mild cognitive impairment (20).
Another fundamental and well-documented factor is polypharmacy 
(21). It has been associated with high morbidity and mortality rates 
in frail, elderly individuals, due to adverse drug reactions, interactions, 
underuse, nonadherence, and inappropriate prescribing. Nevertheless, 
the Screening Tool of Older Person’s potentially inappropriate 
Prescription (STOPP) and START guidelines offer a promising strategy 
to improve appropriate prescribing in the elderly adults (22). Moreover, 
emerging studies dealing with frailty have begun to ascertain whether it 
could be slowed down or even reversed with multi-intervention clinical 
trials (11,23,24) and have reported modest but encouraging outcomes.
The objective of our trial was to assess the effectiveness of a mul-
tifactorial intervention to modify frailty parameters: physical dimen-
sions (muscle strength, elasticity, balance), cognitive performance, 
and polypharmacy in frail, elderly community-dwelling individuals. 
We carried out a 12-week multidisciplinary intervention involving 
clinicians, physiotherapists, speech therapists, and social workers, 
based on structured physical activity, diet supplementation, memory 
workshops, and medication review.
Methods
Study Design and Setting
A prospective, single-blind, parallel-group, pragmatic, rand-
omized, multicenter, clinical trial was performed with an 18-month 
follow-up. Details of the methods have been previously published 
(25). Trial registration: ClinicalTrials.gov NCT01969526.
The study was conducted at 8 primary health care centers and 
involved 352 community-dwelling adults aged older than 65 from 
different areas of Barcelona. Changes from baseline frailty meas-
urements at enrollment were compared between the intervention 
(IG) and control group (CG) at the end of the intervention, and 
18 months later.
Participants and Recruitment
Inclusion criteria were: set gait time between 10 and 30 seconds in 
the Timed Get-up-and-Go test (TGUGT); scored Mini-Examination 
Cognitive of Lobo (MEC-35 Lobo) ≥18 points (no severe cognitive 
impairment); and Fried modified criteria. See Supplementary Table 1 
for further details.
Eligible participants were randomized 1:1 to the IG and CG. 
Sequence was concealed until the interventions were assigned. 
Baseline and outcome measurements were blinded to group assign-
ment. Follow-up evaluations were conducted by blind, clinical 
researchers. Figure 1 describes the flow-diagram of participants.
Intervention
Briefly, participants in the IG received a multidisciplinary multifac-
torial therapy, consecutively applied to each subject in groups of 16 
participants:
1. Structured physical activity, providing a well-established aerobics 
exercise program in each primary health care center, a 60-minute 
session twice a week on non-consecutive days for 6 weeks, con-
ducted by physiotherapists.
2. Intake of 1 hyperproteic nutritional shake (Meritene Activ; 
Nestlé Health Science-NHS), which was taken daily for 6 weeks 
during the exercise training.
Figure 1. CONSORT diagram reflecting flow of study participants.
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3. Memory workshops, consisting of a 90-minute session twice a 
week, 12 sessions of practical exercises (written, oral, corporal, and 
musical), conducted by speech therapists from the Rehabilitation 
Unit.
4. Medication Review, following STOPP criteria, with special focus 
on psychotropic drugs.
Control participants received the usual care. Both groups were also 
given counseling regarding dietary habits, lifestyle recommenda-
tions, and domestic hazards.
Outcome Variables
1. Physical Dimension:
a) SPPB, a standardized assessment tool of lower limb function 
(standing balance, repeated chair stands, gait speed).
b) Evaluation of upper extremities’ strength by a handgrip dyna-
mometer (HG).
c) Functional Reach Test which measures standing balance and 
stretching.
d) Unipodal Station Test which measures balance.
2. Neuropsychological Performance:
a) Short and Medium-Term Verbal Memory.
b) Animal Naming Test which scores semantic verbal fluency 
category.
c) Evocation of words beginning with one explicit letter which 
scores phonetic verbal fluency category.
d) Designation of famous people’s names, which scores phono-
logical retrieval failure.
e) Verbal designation of images which scores visual recognition 
memory.
f) Verbal abstraction of word pairs which scores connection 
between verbal recognition memory and neuroprocessing 
mechanisms.
3. Medication. Number of prescriptions.
See Supplementary Methods for further details.
Statistics
Outcome variables were assessed at baseline and at 3 and 18 months 
after randomization. Consistent with the protocol design, an inten-
tion-to-treat approach was employed. The incomplete cases were 
handled using the multiple imputation analysis by “mi impute pmm” 
procedure in Stata IC v12 statistical software. The estimates of the 
parameters for each imputed data set were combined using Rubin’s 
rules (26). Sensitivity analyses comparing complete cases versus mul-
tiple imputation analysis are shown in Supplementary Table 3.
The change of each outcome during the follow-up was assessed 
by multilevel mixed-effects linear regression adjusted by age, gender, 
marital status, educational status, income, and baseline TGUG and 
MEC-35. Interaction terms between the intervention, gender, and 
age were also tested and none were statistically significant.
Standardized effect sizes were calculated as the mean difference 
between IG and CG, divided by the pooled standard deviation of 
CG and IG change (27). Estimates were reported with corresponding 
95% confidence intervals, and statistical significance was established 
as a p value less than .05.
Results
Between January 2013 and January 2015, participants were rand-
omized to the multi-intervention (n = 176) or the control (n = 176) 
groups. The main characteristics of our study sample according to 
randomization group are presented in Table 1. A total of 265 partici-
pants (75.3%) were female, mean age 77.3 years, nearly half of them 
living alone (47.2%), The baseline features of the two groups were 
similar in terms of inclusion criteria, age, sex, civil status, cohabit-
ation, comorbidity, and biological variables, including nutritional, 
functional, and mental performance, as shown in Supplementary 
Table 2.
At the 12-week evaluation, follow-up data from 173 partici-
pants in the IG and 174 in the CG were available for analysis. At 
18 months, 148 and 119 participants were reassessed, respectively 
(76% of the baseline sample, see Figure  1). The participants that 
were not assessed at the 18-month interview (n = 85) were similar 
to the interviewed group in terms of gender and baseline inclusion 
criteria, but 2 years older. Sixty-seven percent of the missing data 
group belonged to the CG, but there were no differences in baseline 
characteristics between IG and CG in terms of age, gender, inclusion 
criteria, and SPPB.
After the intervention, there were significant improvements in all 
major variables related to frailty measures in the IG while in the 
CG the result was inverse. There was a significant average increase 
of the difference between groups in SPPB score means adjusted by 
potential confounders at 3 and 18 months: 1.58 and 1.36 (p < .001), 
respectively. Standardized effect sizes at 3 and 18 months were rated 
as very large (1.18) and moderate (0.69), respectively.
Similar results were seen in strength of upper extremities and 
balance measurements, and in the mental performance battery, with 
also significant mean improvements between groups and medium 
and large standardized effect size indices at 3 months, but small at 
18 months. All evaluated changes in physical and cognitive perfor-
mance at 3 and 18 months are shown in Tables 2 and 3. Percentage 
of polypharmacy decreased 9.6% in the IG, but increased 4.5% in 
the CG after the intervention. Prescribed benzodiazepines decreased 
in the IG compared to the CG (−0.011 vs +0.023) but did not reach 
statistical significance.
In the IG, the mean number of sessions attended was 13, out of 
a total of 24 in the program. Figure 2 shows mean change in the 
physical and cognitive variables at 3 months according to the range 
of sessions attended.
Finally, attendance at the educational sessions was 48% in the 
CG and 52% in the IG.
Discussion
Our main finding is that a combined intervention that includes phys-
ical activity plus protein intake, along with memory workshops and 
medication review, improved functional and cognitive performance 
in frail/prefrail, community-dwelling, older adults at 12 weeks from 
commencing the intervention. The effect was significantly main-
tained up to at least 18 months. To the best of our knowledge, this 
is the first quadruple interventional trial performed to improve dif-
ferent frailty domains.
There is considerable evidence regarding the positive short 
and medium term impact of physical activity on strength, balance, 
and falls in moderately frail, elderly community-dwellers (28,29). 
Consistent with previous studies, our results in the IG showed a 
clear improvement in mobility, balance (better SPPB score), stretch-
ing, and muscle strength (handgrip), showing also sustained effects 
at long term.
Nutritional interventions with protein and energy supplementa-
tion have also reported good results in physical function for elderly 
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people at risk of malnutrition (30). Our study revealed positive 
physical benefits for protein-calorie and micronutrient intake sup-
plementation in association with physical activity, irrespective of 
basal nutritional status. However, further studies are required to 
determine whether this finding is explained by an adding effect or 
attributable to individual variables of dietary intake. As far as we are 
aware, only one study has demonstrated that nutritional supplemen-
tation alone can reduce frailty (31).
Table 2. Change in Physical Performance Measures and Prescriptions Between Intervention and Control Groups at 3 and 18 mo
Control Group N = 176 Intervention Group N = 176
Adjusted Mean Difference (95% CI)  
Between Groups (IG-CG)a,bMean (SD)a Mean (SD)a p Value SESc
Physical tests
SPPB (range 0–12)
 Pre-I 7.3 (2.4) 7.1 (2.3) <.001 1.18
 Post-3 mo 6.8 (2.3) 8.1 (2.2) 1.58 (1.29–1.86)
 Post-18 mo 7.0 (2.6) 8.1 (2.3) 1.36 (0.89–1.83) <.001 0.69
Handgrip (kg)
 Pre-I 16.5 (7.4) 16.5 (7.7) <.001 1.12
 Post-3 mo 15.8 (6.9) 18.6 (7.7) 2.86 (2.32–3.41)
 Post-18 mo 15.7 (7.8) 18.2 (7.9) 2.49 (1.09–3.89) .001 0.41
Functional reach (cm)
 Pre-I 82.2 (9.3) 80.7 (10.1) <.001 0.96
 Post-3 mo 80.7 (8.8) 83.5 (9.3) 4.34 (3.35–5.32)
 Post-18 mo 79.7 (10.5) 82.7 (10.7) 4.52 (2.32–6.72) <.001 0.47
Unipodal station (seconds)
 Pre-I 8.2 (9.7) 6.9 (8.0) <.001 0.75
 Post-3 mo 7.3 (9.2) 9.6 (9.1) 3.58 (2.57–4.59)
 Post-18 mo 7.7 (9.0) 9.3 (8.7) 2.98 (1.11–4.84) .002 0.37
Number of drugs/day
 Pre-I 6.6 (3.8) 7.7 (3.2) <.001 0.99
 Post-3 mo 7.2 (4.0) 6.9 (3.2) −1.39 (−1.69–−1.10)
 Post-18 mo 7.5 (4.1) 7.5 (3.4) −1.09 (−1.71–−0.47) .001 0.37
Note: CG = Control group; CI = Confidence interval; I = Intervention; IG = Intervention group; N = Number; SD = Standard deviation; SES = Standardized effect 
size; SPPB = Short physical performance battery.
aIntention to treat analyses using missing value imputation. bMultilevel mixed-effects linear regression adjusted by age, gender, marital status, educational status, 
income, MEC-35 Lobo, TGUGT. cCohen’s d.
Table 1. Baseline Characteristics by Treatment Group
Control Group (n = 176) Intervention Group (n = 176) p Value
Gender, n (%) Male 45 (25.6) 42 (23.9) .711
Female 131 (74.4) 134 (76.1)
Age, years, mean (SD) 77.4 (7.7) 77.2 (6.8) .770
Living alone, n (%) 83 (47.2) 83 (47.2) 1.00
Marital Status, n (%) Single 23 (13.1) 22 (12.5) .884
Widowed 76 (43.2) 80 (45.5)
Married 67 (38.1) 67 (38.1)
Divorced 10 (5.7) 7 (4.0)
Educational status, n (%) Unfinished studies 67 (38.1) 78 (44.3) .037
Primary school 80 (45.5) 60 (34.1)
Secondary school 25 (14.2) 25 (14.2)
University degree 4 (2.3) 13 (7.4)
Falls, previous year, n (%) 59 (33.5) 57 (32.4) .821
Hospital admissions, previous year, n (%) 33 (18.8) 40 (22.7) .357
MEC-35 Lobo score, mean (SD) 30.6 (4.1) 31.2 (3.2) .135
Lawton & Brody Scale, mean (SD) 6.5 (1.9) 6.6 (1.76) .660
Barthel Index, mean (SD) 96.1 (7.5) 96.0 (6.2) .938
Number of drugs/day, mean (SD) 6.6 (3.8) 7.7 (3.2) .004
Charlson Index, mean (SD) 1.3 (1.5) 1.5 (1.6) .203
TGUGT, mean (SD) 14.5 (4.9) 15.0 (4.9) .368
Frailty criteria, n (%)a Prefrail 44 (25.0) 45 (25.6) .900
Frail 132 (75.0) 131 (74.4)
Note: n = number of subjects; SD = Standard deviation; TGUGT = Timed get up and go test.
aAdapted from ref. (2).
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Frailty and cognition interact in the cycle leading to disability 
and dependency (32), and interventions in cognitive areas should be 
encouraged to prevent or even reverse further physical decline (33). 
It has also been reported that physical exercise training improves 
cognitive functioning and psychological well-being in frail, older 
adults (34). In agreement with these studies, we found that cognitive 
training program targeting short and medium-term memory, atten-
tion, and executive functions, along with physical training, had an 
effect on cognition (significant changes in memory and abstraction 
tests), and also improved motor balance and strength. Transference 
of cognitive remediation effects to mobility, as described by other 
authors (33), could be related to an indirect enhancement of social 
and functioning abilities among the IG participants.
An association between polypharmacy and frailty has been reported 
(35), and polypharmacy itself is considered to be a risk factor for nega-
tive outcomes (falls, cognitive impairment, mortality). As expected, our 
review of all medicated subjects led to a reduction of prescriptions (an 
average of one drug per subject, especially psychotropic medication). In 
concurrence with recent studies (36), the reduction was more effective 
in patients receiving polypharmacy than those who were not.
The combination of complex strategies is nowadays considered 
the optimum approach to improve frailty standards of care beyond 
current clinical practice (37). Recently, a comprehensive review (38) 
highlighted promising results related to these individually- tailored, 
Table 3. Change in Neuropsychological Performance Measures Between Intervention and Control Groups at 3 and 18 mo
Control Group N = 176 Intervention Group N = 176
Adjusted Mean Difference (95% CI)  
Between Groups (IG-CG)a,bMean (SD)a Mean (SD)a p Value SESc
Short-Term Verbal Memory (range 0–21)
 Pre-I 5.6 (2.5) 5.3 (2.7) <.001 0.67
 Post-3 mo 5.0 (2.2) 5.9 (2.7) 1.19 (0.82–1.57)
 Post-18 mo 5.0 (2.4) 5.3 (2.2) 0.67 (0.13–1.21) .015 0.28
Medium-Term Verbal Memory: Retest (range 0–21)
 Pre-I 4.0 (2.3) 3.9 (2.4) <.001 0.71
 Post-3 mo 3.8 (1.9) 4.9 (2.4) 1.11 (0.78–1.44)
 Post-18 mo 3.4 (2.2) 4.0 (2.1) 0.69 (0.12–1.21) .016 0.31
Animal Naming Test
 Pre-I 15.0 (5.1) 15.2 (4.6) <.001 0.77
 Post-3 mo 14.4 (4.9) 16.6 (4.8) 2.01 (1.46–2.56)
 Post-18 mo 14.7 (5.3) 15.9 (4.7) 1.05 (0.12–1.97) .026 0.26
Evocation of words
 Pre-I 19.1 (7.9) 19.4 (8.5) <.001 0.93
 Post-3 mo 17.8 (7.1) 21.9 (8.8) 3.64 (2.81–4.47)
 Post-18 mo 18.3 (7.9) 20.8 (8.0) 2.10 (0.50–3.71) .010 0.32
Designation of famous people’s names
 Pre-I 19.8 (6.1) 20.8 (6.2) <.001 0.67
 Post-3 mo 19.1 (5.8) 22.1 (6.1) 1.92 (1.31–2.53)
 Post-18 mo 20.7 (6.3) 22.4 (6.2) 0.71 (−0.41–1.83) .212 0.15
Verbal designation of images (number in ≤3 seconds)
 Pre-I 13.1 (1.2) 13.1 (1.4) <.001 0.59
 Post-3 mo 12.8 (1.6) 13.5 (1.1) 0.71 (0.46–0.97)
 Post-18 mo 12.9 (1.6) 13.4 (1.2) 0.53 (0.20–0.86) .002 0.36
Verbal abstraction of word pairs
 Pre-I 3.5 (1.4) 3.5 (1.5) <.001 0.35
 Post-3 mo 3.2 (1.3) 3.6 (1.5) 0.40 (0.16–0.65)
 Post-18 mo 2.7 (1.5) 3.1 (1.6) 0.46 (0.40–0.89) .032 0.25
Note: CG = Control group; CI = Confidence interval; I = Intervention; IG = Intervention group; N = Number; SD = Standard deviation; SES = Standardized effect 
size; SPPB = Short physical performance battery.
aIntention to treat analyses using missing value imputation. bMultilevel mixed-effects linear regression adjusted by age, gender, marital status, educational status, 
income, MEC-35 Lobo, TGUGT. c Cohen’s d.
Figure  2. Mean change score (95% CI) in outcome variables at 3  months, 
stratified by total number of sessions attended in the intervention 
group. Note: 0  =  no sessions attended; 1  =  1–12 sessions; 2  =  13–24 
sessions; SPPB  =  Short physical performance battery; HG  =  Hand grip; 
F.R. = Functional reach; U.POD = Unipodal station; R.ST = Short-term verbal 
memory; RET = Medium-term verbal memory; ANIM = Animal naming test; 
PW = Evocation of words beginning with P; FACES = Designation of people’s 
names; IMAG = Designation of images; ABSTR = Verbal abstraction of pairs.
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multidisciplinary interventions, which appear to produce short-
medium term benefits in decelerating frailty.
As previously stated, this is the first randomized controlled trial 
with intention-to-treat analysis which adds the novelty of concomitant 
cognition and medication interventions and their postevaluation. Our 
multistrategy resulted in a clear improvement in mobility and strength 
performance tests, enhancement of mental performance, and reduc-
tion of polypharmacy, with marked effect sizes for most comparisons 
at 3 months follow-up. Moreover, despite the fact that the interven-
tion was not maintained beyond 3 months, significant improvements 
were still observed at 18 months. In contrast, in a study conducted in 
Sydney, the benefit of a multidomain intervention was not evident at 
12 weeks follow-up and only apparent at 12 months (23).
Frailty is globally considered to be reversible and preventable in 
its initial phases (6), and prefrailty is a field of growing interest. Thus, 
identifying the target population for enrollment in programs address-
ing this issue is a challenge. Based on gait speed and balance (TGUGT), 
our study tackled a full segment of community-dwellers who ranged 
from prefrail to medium-frail when applying Fried criteria. We found 
similar improvements in all the patients’ parameters, suggesting that 
triage through simple performance measures such as TGUGT could be 
sufficient to enroll the elderly in potentially effective activities.
Following the guidelines of the Frailty Working Group (39), 
we carried out physical assessment through several complemen-
tary tests the results of which were partly self-reported and partly 
performance-based. Nevertheless, the primary outcomes (the SPPB, 
neurocognitive tests, and prescriptions) were objective measures that 
should reduce observer bias.
In contrast to other studies (30), our intervention was designed as 
a global, combined approach. Thus, the individual effect of protein 
supplementation and memory workshops could not be analyzed. 
Another limitation could be that, as nutritional parameters did not 
form part of the inclusion criteria, it is difficult to assess the real 
effect of the protein intake in the IG.
Intention-to-treat analysis was conducted to assess final out-
comes, and missing values imputation and sensitivity analyses 
were performed using the recommended strategy (26). Although 
at 12 weeks only five individuals were not contacted, at 18 months 
24% of the sample could not be reassessed (mainly from the CG) 
either due to worse health status or lacking motivation to par-
ticipate in the reassessment. Nevertheless, bias caused by differ-
ential losses seems unlikely as baseline characteristics are similar 
between IG and CG in the complete data and missing data groups. 
Full attendance at the exercise activities and memory workshops 
was not achieved by most participants: mean attendance was 13 
out of 24 sessions. We found a dose-respond pattern between 
number of attended sessions and improvements in physical out-
comes, although this pattern was inconsistent in the cognitive ones 
(Figure 2).
As with the frailty phenotype, baseline characteristics were not 
likely to affect the intensity of the effect we found, and the final 
model was adjusted to those characteristics. Neither was any gender 
interaction observed, the effect was similar in both men and women.
There were no adverse events. Occasional absences from the ses-
sions were due to external social events or acute-short illness unre-
lated to the intervention.
The intervention is readily transferable to routine clinical prac-
tice in integrated, elderly, healthcare settings with specific, clinic-
ally experienced teams. Indeed, it would be of interest to conduct 
trials testing the intervention in different environments, where 
our experience could be easily adapted. In this regard, the myriad 
physical, cognitive, and social activities taking place in most com-
munities, if properly designed and conducted, could easily replace 
the more supervised and controlled interventions performed in trials. 
Moreover, the economic burden of falls, hospital admissions, and 
disability in the elderly is greater than the cost-effective specific inter-
ventions that could be carried out (40). Adherence to interventions 
may be a handicap. Nevertheless, although participants in the IG 
did not attend all the activities, we still found high adherence mainly 
due mainly to their enjoying social interaction in historically pro-
active districts. Although the intervention was limited to 3 months, 
the enhancement of community networks may also have added to 
the sustained long-term improvement found in the IG.
Conclusions
The results of this study provide further evidence regarding the ben-
eficial effect for frail, elderly individuals of a multifactorial interven-
tion including exercise training (combining functional, resistance, 
and aerobic exercise modes), protein intake, cognition workshops, 
and medication review as a global strategy to reduce loss of auton-
omy and its risk factors. Our findings show the feasibility of identify-
ing frail/prefrail individuals through simple performance measures in 
primary care settings, and how a multidisciplinary, coordinated care 
approach improves function and cognition in elderly community-
dwellers. Our results, the long term changes in frailty parameters, 
and the social empowerment achieved, may lead to the prevention 
of future negative outcomes in the frail population. The scalability 
of our intervention encourages future collaboration with community 
organizations in elderly-friendly cities.
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